Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 93
Filtrar
Mais filtros

Medicinas Complementares
Tipo de documento
Intervalo de ano de publicação
1.
Physiol Rep ; 11(8): e15667, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-37078367

RESUMO

Many kinds of fish are characterized by a limited efficiency to use carbohydrates. For this reason, raw fish and mixed feed containing a lot of fish meal have been used as feed for fish farming. However, continuing to use high-protein diets not only increases the cost of fish farming, but may also fuel animal protein shortages. Furthermore, carbohydrates are added to improve the texture of the feed and act as a binding agent and are usually contained at 20% in the feed. It makes sense, therefore, to find ways to make good use of carbohydrates rather than wasting them. The physiological mechanisms of glucose intolerance in fish are not yet well understood. Therefore, we investigated the glucose utilization of fish, omnivorous goldfish Carassius auratus and carnivorous rainbow trout Oncorhynchus mykiss. Furthermore, the effects of oral administration of wild plant-derived minerals and red ginseng on the glucose utilization in these fish muscle cells were investigated. As a result, we found the following. (1) An extremely high insulin resistance in fish muscle and the symptom was more pronounced in carnivorous rainbow trout. (2) Administration of wild plant-derived minerals promotes the translocation of the insulin-responsive glucose transporter GLUT4 to the cell surface of white muscle via activation of the PI3 kinase axis, whereas administration of red ginseng not only promotes GLUT4 transfer and translocation to the cell surface of white muscle via AMPK activation as well as promoting glucose uptake into muscle cells via a pathway separate from the insulin signaling system. (3) In fish, at least goldfish and rainbow trout, both PI3K/Akt and AMPK signaling cascades exist to promote glucose uptake into muscle cells, as in mammals.


Assuntos
Carpa Dourada , Resistência à Insulina , Minerais , Oncorhynchus mykiss , Panax , Plantas , Transdução de Sinais , Administração Oral , Proteínas Quinases Ativadas por AMP/metabolismo , Comportamento Animal , Glucose/metabolismo , Teste de Tolerância a Glucose , Carpa Dourada/metabolismo , Minerais/farmacologia , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Oncorhynchus mykiss/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Plantas/química , Proteínas Proto-Oncogênicas c-akt/metabolismo , Transdução de Sinais/efeitos dos fármacos , Animais
2.
Biomolecules ; 11(10)2021 10 04.
Artigo em Inglês | MEDLINE | ID: mdl-34680087

RESUMO

Withania somnifera (Ashwagandha) is used in Indian traditional medicine, Ayurveda, and is believed to have a variety of health-promoting effects. The molecular mechanisms and pathways underlying these effects have not yet been sufficiently explored. In this study, we investigated the effect of Ashwagandha extracts and their major withanolides (withaferin A and withanone) on muscle cell differentiation using C2C12 myoblasts. We found that withaferin A and withanone and Ashwagandha extracts possessing different ratios of these active ingredients have different effects on the differentiation of C2C12. Withanone and withanone-rich extracts caused stronger differentiation of myoblasts to myotubes, deaggregation of heat- and metal-stress-induced aggregated proteins, and activation of hypoxia and autophagy pathways. Of note, the Parkinson's disease model of Drosophila that possess a neuromuscular disorder showed improvement in their flight and climbing activity, suggesting the potential of Ashwagandha withanolides for the management of muscle repair and activity.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Extratos Vegetais/química , Vitanolídeos/farmacologia , Animais , Linhagem Celular , Humanos , Ayurveda/tendências , Camundongos , Células Musculares/efeitos dos fármacos , Doença de Parkinson/tratamento farmacológico , Doença de Parkinson/patologia , Extratos Vegetais/farmacologia , Vitanolídeos/química
3.
J Ethnopharmacol ; 271: 113849, 2021 May 10.
Artigo em Inglês | MEDLINE | ID: mdl-33485983

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Saussurea laniceps Hand.-Mazz. (Compositae) is a representative "snow lotus" herb well known in Chinese folk medicine to treat inflammation-related diseases such as arthritis. S. laniceps (SL) shows anti-inflammatory and analgesic potencies and contains various constituents potentially with cyclooxygenase-2 (COX-2) selective inhibition. The herb is a valuable source of natural alternatives to synthetic COX-2 selective nonsteroidal anti-inflammatory drugs, a common medication for rheumatoid arthritis (RA) and osteoarthritis (OA) reported with serious cardiovascular side effects. AIM OF THE STUDY: Based on an innovative drug screening platform, this study aimed to discover safe, effective COX-2 selective inhibitors from SL. MATERIALS AND METHODS: An enzyme-anchored nanomagnetic fishing assay was developed to separate COX-2 ligands from SL. Cell and animal models of cardiomyocytes, lipopolysaccharide-stimulated macrophages, rat adjuvant-induced arthritis, and anterior cruciate ligament transection-induced OA rats, were adopted to screen the single/combined ligands regarding toxicity and bioactivity levels. Molecular docking was employed to unravel binding mechanisms of the ligands towards COX-1 and COX-2. RESULTS: Four COX-2 selective compounds were separated from SL using optimized COX-2-functionalized magnetic nanoparticles. All the four ligands were proved with evidently lower cardiotoxicity both in vitro and in vivo than celecoxib, a known COX-2 selective inhibitor. Two ligands, scopoletin and syringin, exhibited potent anti-arthritic activities in rat models of RA and OA by alleviating clinical statuses, immune responses, and joint pathological features; their optimum combination ratio was discovered with stronger remedial effects on rat OA than single administrations. The COX-1/2 binding modes of the two phytochemicals contributed to explain their cardiac safety and therapeutic performances. CONCLUSIONS: The screened chemicals are promising to be developed as COX-2 selective inhibitors as part of treating RA and OA. The hybrid strategy for discovering therapeutic agents from SL is shown here to be efficient; it should be equally valuable for finding other active chemicals in other natural sources.


Assuntos
Inibidores de Ciclo-Oxigenase 2/química , Inibidores de Ciclo-Oxigenase 2/isolamento & purificação , Descoberta de Drogas/métodos , Medicamentos de Ervas Chinesas/farmacologia , Nanopartículas Magnéticas de Óxido de Ferro/química , Nanoconjugados/química , Saussurea/química , Animais , Artrite Experimental/induzido quimicamente , Artrite Experimental/tratamento farmacológico , Artrite Experimental/patologia , Celecoxib/efeitos adversos , Linhagem Celular , Ciclo-Oxigenase 2/química , Ciclo-Oxigenase 2/metabolismo , Inibidores de Ciclo-Oxigenase 2/efeitos adversos , Inibidores de Ciclo-Oxigenase 2/farmacologia , Medicamentos de Ervas Chinesas/efeitos adversos , Medicamentos de Ervas Chinesas/química , Glucosídeos/efeitos adversos , Glucosídeos/farmacologia , Articulações/diagnóstico por imagem , Articulações/patologia , Ligantes , Simulação de Acoplamento Molecular , Células Musculares/efeitos dos fármacos , Osteoartrite/tratamento farmacológico , Osteoartrite/etiologia , Fenilpropionatos/efeitos adversos , Fenilpropionatos/farmacologia , Componentes Aéreos da Planta/química , Ratos Sprague-Dawley , Escopoletina/efeitos adversos , Escopoletina/farmacologia , Remodelação Ventricular/efeitos dos fármacos
4.
Acta Pharmacol Sin ; 42(5): 735-743, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-32770172

RESUMO

Insulin resistance (IR) is a major metabolic risk factor even before the onset of hyperglycemia. Recently, berberine (BBR) is found to improve hyperglycemia and IR. In this study, we investigated whether BBR could improve IR independent of hyperglycemia. Acute insulin-resistant state was induced in rats by systemic infusion of intralipid (6.6%). BBR was administered via different delivery routes before or after the beginning of a 2-h euglycemic-hyperinsulinemic clamp. At the end of experiment, rats were sacrificed, gastrocnemius muscle was collected for detecting mitochondrial swelling, phosphorylation of Akt and AMPK, as well as the mitochondrial permeability regulator cyclophilin D (CypD) protein expression. We showed that BBR administration markedly ameliorated intralipid-induced IR without affecting blood glucose, which was accompanied by alleviated mitochondrial swelling in skeletal muscle. We used human skeletal muscle cells (HSMCs), AML12 hepatocytes, human umbilical vein endothelial cells, and CypD knockout mice to investigate metabolic and molecular alternations. In either HSMCs or AML12 hepatocytes, BBR (5 µM) abolished palmitate acid (PA)-induced increase of CypD protein levels. In CypD-deficient mice, intralipid-induced IR was greatly attenuated and the beneficial effect of BBR was diminished. Furthermore, we demonstrated that the inhibitory effect of BBR on intralipid-induced IR was mainly mediated by skeletal muscle, but not by intestine, liver, or microvasculature; BBR administration suppressed intralipid-induced upregulation of CypD expression in skeletal muscle. These results suggest that BBR alleviates intralipid-induced IR, which is related to the inhibition of CypD protein expression in skeletal muscle.


Assuntos
Berberina/uso terapêutico , Hiperinsulinismo/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Resistência à Insulina/fisiologia , Animais , Linhagem Celular , Ciclofilinas/metabolismo , Emulsões , Humanos , Hiperinsulinismo/induzido quimicamente , Hiperinsulinismo/metabolismo , Masculino , Camundongos , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Fosfolipídeos , Ratos Sprague-Dawley , Óleo de Soja
5.
Chin J Nat Med ; 18(12): 907-915, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33357721

RESUMO

Cardiovascular disease is the main cause of mortality and morbidity in the world, especially in developing countries. Drug therapy is one of the main ways to treat cardiovascular diseases. Among them, great progress has been made in the treatment of cardiovascular diseases with traditional Chinese medicine. In terms of experimental research, the mechanism of traditional Chinese medicine in the treatment of cardiovascular diseases has been thoroughly discussed in vitro and in vivo. In terms of clinical treatment, traditional Chinese medicine with flavonoids, saponins and alkaloids as the main effective components has a definite effect on the treatment of cardiovascular diseases such as arrhythmia, myocardial ischemia, angina pectoris and myocardial infarction, with high safety and good application prospects. With the further research on the effective ingredients, mechanism and adverse reactions of traditional Chinese medicine, it will be beneficial to the effectiveness of traditional Chinese medicine, reduce side effects and promote the modernization of traditional Chinese medicine. Calycosin and its derivatives, the main bioactive flavonoids in Astragalus membranaceus have multiple biological effects, such as antioxidant, pro-angiogenesis, anti-tumour, and anti-inflammatory effects. Based on the above biological effects, calycosin has been shown to have good potential for cardiovascular protection. The potent antioxidant effect of calycosin may play an important role in the cardiovascular protective potential. For injured cardiac myocytes, calycosin and its derivatives can alleviate the cell damage mainly marked by the release of myocardial enzymes and reduce the death level of cardiac myocytes mainly characterized by apoptosis through various mechanisms. For vascular endothelial cells, calycosin also has multiple effects and multiple mechanisms, such as promoting vascular endothelial cell proliferation, exerting vasodilating effect and directly affecting the synthesis function of endothelial cells. The present review will address the bioactivity of calycosin in cardiovascular diseases such as protective effects on cardiac myocytes and vascular endothelial cells and elucidate main mechanism of calycosin and its derivatives to exert the above biological effects.


Assuntos
Cardiotônicos/farmacologia , Doenças Cardiovasculares/tratamento farmacológico , Medicamentos de Ervas Chinesas/farmacologia , Isoflavonas/farmacologia , Apoptose/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Humanos , Medicina Tradicional Chinesa , Células Musculares/efeitos dos fármacos
6.
Cell Transplant ; 29: 963689720960190, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33081508

RESUMO

The purpose of this study was to investigate whether the ERK signaling pathway was involved in ameliorating chronic myofascial hyperalgesia from contused gastrocnemius muscle in rats. We established an animal model associated with myofascial pain syndrome and described the mechanism of muscle pain in an animal model. Changes in the mechanical pain threshold were observed 0.5, 1, 2, 3, 4, 5, 8, 12, 18, and 24 h after ERK inhibitor injection around myofascial trigger points (MTrPs) of the gastrocnemius muscle in rats. Morphological changes in gastrocnemius muscle cells were observed by hematoxylin and eosin (H&E) staining. ERK signaling pathway activation was detected through immunohistochemistry and Western blotting. The main morphological characteristics of injured muscle fibers around MTrPs include gathered circular or elliptical shapes of different sizes in the cross-section and continuous inflated and tapering fibers in the longitudinal section. After intramuscular injection of U0126 (ERK inhibitor), the mechanical pain threshold significantly increased. The reduction in mechanical hyperalgesia was accompanied by reduced ERK protein phosphorylation, myosin light chain kinase (MLCK) protein, p-MLC protein expression, and the cross-sectional area of skeletal muscle cells around MTrPs. An ERK inhibitor contributed to the attenuation of mechanical hyperalgesia in the rat myofascial pain model, and the increase in pain threshold may be related to MLCK downregulation and other related contraction-associated proteins by ERK.


Assuntos
Sistema de Sinalização das MAP Quinases , Mialgia/enzimologia , Pontos-Gatilho/patologia , Animais , Hiperalgesia/complicações , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Masculino , Células Musculares/efeitos dos fármacos , Células Musculares/patologia , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/patologia , Mialgia/complicações , Mialgia/patologia , Mialgia/fisiopatologia , Síndromes da Dor Miofascial/complicações , Síndromes da Dor Miofascial/patologia , Síndromes da Dor Miofascial/fisiopatologia , Quinase de Cadeia Leve de Miosina/metabolismo , Limiar da Dor/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Inibidores de Proteínas Quinases/farmacologia , Ratos Sprague-Dawley
7.
Molecules ; 25(12)2020 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-32580297

RESUMO

Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven colorectal cancer (CRC) is notorious to target with drugs and has shown ineffective treatment response. The seeds of Pharbitis nil, also known as morning glory, have been used as traditional medicine in East Asia. We focused on whether Pharbitis nil seeds have a suppressive effect on mutated KRAS-driven CRC as well as reserving muscle cell functions during CRC progression. Seeds of Pharbitis nil (Pharbitis semen) were separated by chromatography and the active compound of Pharbitis semen (PN) was purified by HPLC. The compound PN efficiently suppressed the proliferation of mutated KRAS-driven CRC cells and their clonogenic potentials in a concentration-dependent manner. It also induced apoptosis of SW480 human colon cancer cells and cell cycle arrest at the G2/M phase. The CRC related pathways, including RAS/ERK and AKT/mTOR, were assessed and PN reduced the phosphorylation of AKT and mTOR. Furthermore, PN preserved muscle cell proliferation and myotube formation in cancer conditioned media. In summary, PN significantly suppressed mutated KRAS-driven cell growth and reserved muscle cell function. Based on the current study, PN could be considered as a promising starting point for the development of a nature-derived drug against KRAS-mutated CRC progression.


Assuntos
Proliferação de Células/efeitos dos fármacos , Neoplasias Colorretais/tratamento farmacológico , Ipomoea nil/química , Proteínas Proto-Oncogênicas p21(ras)/genética , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Cromatografia Líquida de Alta Pressão , Neoplasias Colorretais/genética , Neoplasias Colorretais/patologia , Humanos , Células Musculares/efeitos dos fármacos , Células Musculares/patologia , Mutação/efeitos dos fármacos , Sementes/química
8.
Sci Rep ; 10(1): 10463, 2020 06 26.
Artigo em Inglês | MEDLINE | ID: mdl-32591558

RESUMO

Abscisic acid is a phytohormone found in fruits and vegetables and is endogenously produced in mammals. In humans and mice, lanthionine synthetase C-like 2 (LANCL2) has been characterized as the natural receptor for ABA. Herein, we characterize the efficacy of a fig fruit extract of ABA in promoting glycemic control. This ABA-enriched extract, at 0.125 µg ABA/kg body weight, improves glucose tolerance, insulin sensitivity and fasting blood glucose in diet-induced obesity (DIO) and db/db mouse models. In addition to decreasing systemic inflammation and providing glycemic control without increasing insulin, ABA extract modulates the metabolic activity of muscle. ABA increases expression of important glycogen synthase, glucose, fatty acid and mitochondrial metabolism genes and increases direct measures of fatty acid oxidation, glucose oxidation and metabolic flexibility in soleus muscle cells from ABA-treated mice with DIO. Glycolytic and mitochondrial ATP production were increased in ABA-treated human myotubes. Further, ABA synergized with insulin to dramatically increase the rate of glycogen synthesis. The loss of LANCL2 in skeletal muscle abrogated the effect of ABA extract in the DIO model and increased fasting blood glucose levels. This data further supports the clinical development of ABA in the treatment of pre-diabetes, type 2 diabetes and metabolic syndrome.


Assuntos
Ácido Abscísico/farmacologia , Ficus/química , Inflamação/tratamento farmacológico , Resistência à Insulina/fisiologia , Proteínas de Membrana/metabolismo , Músculo Esquelético/efeitos dos fármacos , Proteínas de Ligação a Fosfato/metabolismo , Extratos Vegetais/farmacologia , Animais , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Modelos Animais de Doenças , Glucose/metabolismo , Humanos , Inflamação/metabolismo , Insulina/metabolismo , Camundongos , Camundongos Endogâmicos NOD , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Músculo Esquelético/metabolismo , Obesidade/metabolismo
9.
Lasers Med Sci ; 35(5): 1047-1054, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31754908

RESUMO

Snakebites caused by the genus Bothrops are often associated with severe and complex local manifestations such as edema, pain, hemorrhage, and myonecrosis. Conventional treatment minimizes the systemic effects of venom; however, their local action is not neutralized. The purpose of this study was to evaluate the effect of photobiomodulation (PBM) on C2C12 muscle cells exposed to B. jararaca, B. jararacussu, and B. moojeni venoms on events involved in cell death and the release of inflammatory mediators. Cells were exposed to venoms and immediately irradiated with low-level laser (LLL) application in continuous wave at the wavelength of 660 nm, energy density of 4.4 J/cm2, power of 10 mW, area of 0.045 cm2, and time of 20 s. Cell integrity was analyzed by phase contrast microscope and cell death was performed by flow cytometry. In addition, interleukin IL1-ß, IL-6, and IL-10 levels were measured in the supernatant. Our results showed that the application of PBM increases cell viability and decreases cell death by apoptosis and necrosis. Moreover, the release of pro-inflammatory interleukins was also reduced. The data reported here indicate that PBM resulted in cytoprotection on myoblast C2C12 cells after venom exposure. This protection involves the modulation of cell death mechanism and decreased pro-inflammatory cytokine release.


Assuntos
Apoptose/efeitos dos fármacos , Bothrops/metabolismo , Venenos de Crotalídeos/toxicidade , Citocinas/biossíntese , Terapia com Luz de Baixa Intensidade , Células Musculares/patologia , Animais , Linhagem Celular , Forma Celular/efeitos dos fármacos , Camundongos , Células Musculares/efeitos dos fármacos , Células Musculares/efeitos da radiação
10.
Artigo em Inglês | WPRIM | ID: wpr-881036

RESUMO

Cardiovascular disease is the main cause of mortality and morbidity in the world, especially in developing countries. Drug therapy is one of the main ways to treat cardiovascular diseases. Among them, great progress has been made in the treatment of cardiovascular diseases with traditional Chinese medicine. In terms of experimental research, the mechanism of traditional Chinese medicine in the treatment of cardiovascular diseases has been thoroughly discussed in vitro and in vivo. In terms of clinical treatment, traditional Chinese medicine with flavonoids, saponins and alkaloids as the main effective components has a definite effect on the treatment of cardiovascular diseases such as arrhythmia, myocardial ischemia, angina pectoris and myocardial infarction, with high safety and good application prospects. With the further research on the effective ingredients, mechanism and adverse reactions of traditional Chinese medicine, it will be beneficial to the effectiveness of traditional Chinese medicine, reduce side effects and promote the modernization of traditional Chinese medicine. Calycosin and its derivatives, the main bioactive flavonoids in Astragalus membranaceus have multiple biological effects, such as antioxidant, pro-angiogenesis, anti-tumour, and anti-inflammatory effects. Based on the above biological effects, calycosin has been shown to have good potential for cardiovascular protection. The potent antioxidant effect of calycosin may play an important role in the cardiovascular protective potential. For injured cardiac myocytes, calycosin and its derivatives can alleviate the cell damage mainly marked by the release of myocardial enzymes and reduce the death level of cardiac myocytes mainly characterized by apoptosis through various mechanisms. For vascular endothelial cells, calycosin also has multiple effects and multiple mechanisms, such as promoting vascular endothelial cell proliferation, exerting vasodilating effect and directly affecting the synthesis function of endothelial cells. The present review will address the bioactivity of calycosin in cardiovascular diseases such as protective effects on cardiac myocytes and vascular endothelial cells and elucidate main mechanism of calycosin and its derivatives to exert the above biological effects.


Assuntos
Humanos , Apoptose/efeitos dos fármacos , Cardiotônicos/farmacologia , Doenças Cardiovasculares/tratamento farmacológico , Proliferação de Células/efeitos dos fármacos , Medicamentos de Ervas Chinesas/farmacologia , Isoflavonas/farmacologia , Medicina Tradicional Chinesa , Células Musculares/efeitos dos fármacos
11.
Biomed Pharmacother ; 120: 109514, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31629948

RESUMO

OBJECTIVE: Tongguan Capsule, a traditional Chinese medicine, is safe to use and is efficient in treating ischemic heart diseases. The present study aimed to investigate whether Tongguan capsule derived-herb (TGD) can mitigate left ventricular remodeling and dysfunction in post myocardial infarction (MI) rats as well as reduce arrhythmias. DESIGN AND METHODS: MI was induced by a ligation of the left anterior descending coronary artery. TGD was administered to the post-MI rats over a period of 4 weeks. TGD treatment significantly attenuated tachyarrhythmia inducibility and cardiac dysfunction in post-MI heart. Echocardiogram showed that TGD significantly reduced the development of ventricular remodeling. Histological study revealed that TGD significantly reduced myocardial interstitial collagen deposition, myocyte area and α-smooth muscle actin (α-SMA) expression, and increased connexin 43 expression in the infarcted border zone (IBZ). Western blotting results revealed that TGD treatment significantly down-regulated the protein expression levels of type I and III collagen, α-SMA, and up-regulated connexin 43. RT-qPCR results showed that TGD decreased the levels of ANP and BNP. CONCLUSIONS: These findings provided strong evidences that TGD intervention ameliorated interstitial fibrosis, myocyte hypertrophy and gap junction expression in the IBZ, attenuated left ventricular remodeling and dysfunction, and reduced vulnerability to tachyarrhythmia. TGD inhibited IBZ remodeling by its inhibition effect on myofibroblasts differentiation.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Infarto do Miocárdio/patologia , Taquicardia Ventricular/prevenção & controle , Fibrilação Ventricular/prevenção & controle , Remodelação Ventricular/efeitos dos fármacos , Animais , Citocinas/genética , Citocinas/metabolismo , Fibrose/prevenção & controle , Regulação da Expressão Gênica/efeitos dos fármacos , Masculino , Células Musculares/efeitos dos fármacos , Peptídeo Natriurético Encefálico/genética , Peptídeo Natriurético Encefálico/metabolismo , Ratos , Ratos Sprague-Dawley
12.
BMC Complement Altern Med ; 19(1): 287, 2019 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-31660942

RESUMO

BACKGROUND: Sarcopenia, the decline of skeletal muscle tissue attributed to primary aging is a major concern in older adults. Flavonoids might have potential benefits by modulating the regulation of satellite cells, thus preventing muscle loss. Sinensetin (SIN), a citrus methylated flavone with anti-inflammatory and anti-proliferative activity, can enhance lipolysis. The objective of the present study was to investigate whether SIN might have sarcopenia-suppressing effect on satellite cells from thigh and calf muscle tissues of young and old rats. METHODS: Primary muscle cells were obtained from thigh and calf tissues of young and old group rats by dissection. Obtained satellite cells were incubated with indicated concentrations of SIN (50 and 100 µM) treated and untreated condition in differentiation medium. Morphological changes of cells were examined using a phase-contrast microscope. Protein expression levels of myoD and myogenin were analyzed by Western blot. Cells treated with or without SIN under differentiation condition were also immunocytochemically stained for myogenin and 4',6-diamidino-2-phenylindole (DAPI). RESULTS: Morphologically, the differentiation extracted satellite cells was found to be more evident in SIN treated group of aged rat's cells than that in SIN untreated group. Expression levels of myoD and myogenin proteins involved in myogenesis were increased upon treatment with SIN. CONCLUSIONS: Collectively, our results indicate that SIN can alleviate age-related sarcopenia by increasing differentiation rate and protein levels of myoD and myogenin.


Assuntos
Envelhecimento/efeitos dos fármacos , Flavonoides/farmacologia , Células Musculares/efeitos dos fármacos , Sarcopenia/tratamento farmacológico , Envelhecimento/genética , Envelhecimento/metabolismo , Animais , Células Cultivadas , Humanos , Masculino , Células Musculares/metabolismo , Desenvolvimento Muscular/efeitos dos fármacos , Músculo Esquelético/citologia , Músculo Esquelético/metabolismo , Proteína MyoD/genética , Proteína MyoD/metabolismo , Miogenina/genética , Miogenina/metabolismo , Ratos , Ratos Sprague-Dawley
13.
Arthritis Res Ther ; 21(1): 182, 2019 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-31370858

RESUMO

BACKGROUND: Patients with rheumatoid arthritis (RA) experience extra-articular manifestations including osteoporosis and muscle wasting, which closely associate with severity of disease. Whilst therapeutic glucocorticoids (GCs) reduce inflammation in RA, their actions on muscle and bone metabolism in the context of chronic inflammation remain unclear. We utilised the TNF-tg model of chronic polyarthritis to ascertain the impact of therapeutic GCs on bone and muscle homeostasis in the context of systemic inflammation. METHODS: TNF-tg and wild-type (WT) animals received either vehicle or the GC corticosterone (100 µg/ml) in drinking water at onset of arthritis. Arthritis severity and clinical parameters were measured, serum collected for ELISA and muscle and bone biopsies collected for µCT, histology and mRNA analysis. In vivo findings were examined in primary cultures of osteoblasts, osteoclasts and myotubes. RESULTS: TNF-tg mice receiving GCs showed protection from inflammatory bone loss, characterised by a reduction in serum markers of bone resorption, osteoclast numbers and osteoclast activity. In contrast, muscle wasting was markedly increased in WT and TNF-tg animals receiving GCs, independently of inflammation. This was characterised by a reduction in muscle weight and fibre size, and an induction in anti-anabolic and catabolic signalling. CONCLUSIONS: This study demonstrates that when given in early onset chronic polyarthritis, oral GCs partially protect against inflammatory bone loss, but induce marked muscle wasting. These results suggest that in patients with inflammatory arthritis receiving GCs, the development of interventions to manage deleterious side effects in muscle should be prioritised.


Assuntos
Artrite/tratamento farmacológico , Reabsorção Óssea/prevenção & controle , Corticosterona/uso terapêutico , Células Musculares/patologia , Atrofia Muscular/prevenção & controle , Osteoblastos/patologia , Osteoclastos/patologia , Animais , Artrite/diagnóstico , Artrite/metabolismo , Biópsia , Reabsorção Óssea/metabolismo , Reabsorção Óssea/patologia , Células Cultivadas , Doença Crônica , Modelos Animais de Doenças , Ensaio de Imunoadsorção Enzimática , Glucocorticoides/uso terapêutico , Camundongos , Camundongos Endogâmicos C57BL , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Atrofia Muscular/metabolismo , Atrofia Muscular/patologia , Osteoblastos/efeitos dos fármacos , Osteoblastos/metabolismo , Osteoclastos/efeitos dos fármacos , Osteoclastos/metabolismo
14.
J Med Food ; 22(8): 779-788, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31210578

RESUMO

Green tea is reported to exert beneficial effects on metabolic disorders through the regulation of lipid metabolism. On the contrary, fermented food products have been introduced to improve human health by modulating immune response and energy metabolism. To maximize health benefit, we applied fermentation processing to green tea. Fermented green tea extract (FGT) inhibited adipogenesis and lipogenesis in cultured adipocytes, whereas it augmented mRNA expression of fatty acid oxidation-related genes in differentiated myocytes. In diet-induced obese mice, FGT blunted body weight and fat mass gain by 69.7% and 56.7%, respectively. FGT also improved circulating triglyceride concentrations by 32.6%. Similar to in vitro results, FGT suppressed lipogenesis and promoted lipid catabolism in peripheral tissues. In addition, FGT administration modulated the composition of certain gut microbiota which are associated with obesity and related metabolic disorders. Among the various components of FGT, gallocatechin gallate is suggested to mediate the effect of FGT on lipid metabolism. Taken together, we propose FGT as a novel functional food to benefit human health by controlling adiposity and lipid metabolism.


Assuntos
Adipócitos/efeitos dos fármacos , Catequina/análogos & derivados , Hipertrigliceridemia/tratamento farmacológico , Metabolismo dos Lipídeos/efeitos dos fármacos , Células Musculares/efeitos dos fármacos , Obesidade/tratamento farmacológico , Extratos Vegetais/administração & dosagem , Adipócitos/metabolismo , Animais , Bacillus subtilis/metabolismo , Camellia sinensis/química , Camellia sinensis/metabolismo , Camellia sinensis/microbiologia , Catequina/administração & dosagem , Catequina/análise , Catequina/metabolismo , Fermentação , Humanos , Lipogênese/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Células Musculares/metabolismo , Obesidade/metabolismo , Extratos Vegetais/análise , Extratos Vegetais/metabolismo , Triglicerídeos/metabolismo
15.
Sci Rep ; 9(1): 1186, 2019 02 04.
Artigo em Inglês | MEDLINE | ID: mdl-30718856

RESUMO

The aging population is growing rapidly around the world and there is also an increase in sarcopenia, which is characterized by decreased muscle mass, strength and function in the elderly population. AMP-activated protein kinase (AMPK) is an essential sensor and regulator of glucose, lipid and energy metabolism throughout the body. Previous studies have shown that AMPK pathway activation by regular exercise and appropriate dietary control have beneficial effects on skeletal muscle. In the process of searching for new AMPK activators from medicinal plants, we isolated and characterized eight new 12,23-dione dammarane triterpenoids (1-3 and 5-9), as well as one known gypentonoside A from Gynostemma longipes. When all isolates were tested for their AMPK activation activities, seven compounds (1 and 3-8) were significantly activated AMPK phosphorylation in mouse C2C12 skeletal muscle cell lines. Since G. longipes contained a significant amount of active compound 1 (over 2.08% per dried raw plant), it suggested the potential of this plant to be developed as a functional food or botanical drug that enhances muscle proliferation by activating AMPK signaling pathways.


Assuntos
Proliferação de Células/efeitos dos fármacos , Gynostemma/química , Células Musculares/efeitos dos fármacos , Proteínas Quinases/metabolismo , Transdução de Sinais/efeitos dos fármacos , Triterpenos/isolamento & purificação , Quinases Proteína-Quinases Ativadas por AMP , Animais , Linhagem Celular , Camundongos , Células Musculares/fisiologia , Compostos Fitoquímicos/química , Compostos Fitoquímicos/isolamento & purificação , Compostos Fitoquímicos/metabolismo , Triterpenos/química , Triterpenos/metabolismo , Damaranos
16.
Poult Sci ; 98(7): 2756-2764, 2019 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-30753670

RESUMO

White striping (WS) and woody breast (WB) are 2 of the major myopathies in the modern poultry industry. Even though the exact etiology for WS and WB is still unknown, differentially expressed genes in broiler breast muscle affected by WS and WB indicate that oxidative stress and inflammation could be involved in their occurrences. Therefore, it is very important to identify natural compounds with anti-oxidative stress and anti-inflammation properties that can reduce the occurrences of WS and WB in broiler chickens. Rutin is a polyphenol antioxidant that has been reported to be present in several plant extracts. In the current study, we established an in vitro inflammation model by using mouse muscle cells (C2C12) and evaluated the effects of rutin on lipopolysaccharide (LPS)-induced inflammatory responses in the muscle cells. Interleukin 6 (IL-6) secretion was measured by enzyme-linked immunosorbent assay. The mRNA abundance of cytokines and inducible nitric oxide synthase (iNOS) was measured by real-time PCR. Nuclear factor kappa B (NF-κB) activation was detected by electrophoretic mobility shift assay. The results showed that LPS (25 ng/ml) stimulation quickly activated NF-κB and induced significant IL-6 expression on both mRNA and protein levels (P < 0.05) in cells when compared with control cells without the LPS treatment. The rutin treatment decreased IL-6 mRNA abundance induced by LPS in a dose-dependent manner (P < 0.05). LPS-induced tumor necrosis factor-alpha and iNOS gene expression was significantly attenuated by 100 µM of rutin (P < 0.05). Moreover, LPS induced reactive oxygen species (ROS) production, and NF-κB activation was significantly blocked by 100 µM of rutin. These results suggest that rutin can attenuate LPS-induced inflammation in muscle cells and supplementation of rutin or rutin-containing plant extracts may present a promising approach to control WS and WB in broiler chickens.


Assuntos
Inflamação/tratamento farmacológico , Células Musculares/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Rutina/farmacologia , Animais , Linhagem Celular , Citocinas , Interleucina-6 , Lipopolissacarídeos/administração & dosagem , Camundongos , NF-kappa B , Óxido Nítrico Sintase Tipo II , RNA Mensageiro , Espécies Reativas de Oxigênio , Fator de Necrose Tumoral alfa
17.
Methods Mol Biol ; 1800: 313-326, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29934900

RESUMO

Ion channels are membrane proteins involved in almost all physiological processes, including neurotransmission, muscle contraction, pace-making activity, secretion, electrolyte and water balance, immune response, and cell proliferation. Due to their broad distribution in human body and physiological roles, ion channels are attractive targets for drug discovery and safety pharmacology. Over the years ion channels have been associated to many genetic diseases ("channelopathies"). For most of these diseases the therapy is mainly empirical and symptomatic, often limited by lack of efficacy and tolerability for a number of patients. The search for the development of new and more specific therapeutic approaches is therefore strongly pursued. At the same time acquired channelopathies or dangerous side effects (such as proarrhythmic risk) can develop as a consequence of drugs unexpectedly targeting ion channels. Several noncardiovascular drugs are known to block cardiac ion channels, leading to potentially fatal delayed ventricular repolarization. Thus, the search of reliable preclinical cardiac safety testing in early stage of drug discovery is mandatory. To fulfill these needs, both ion channels drug discovery and toxicology strategies are evolving toward comprehensive research approaches integrating ad hoc designed in silico predictions and experimental studies for a more reliable and quick translation of results to the clinic side.Here we discuss two examples of how the combination of in silico methods and patch clamp experiments can help addressing drug discovery and safety issues regarding ion channels.


Assuntos
Descoberta de Drogas/métodos , Canais Iônicos/química , Modelos Moleculares , Farmacovigilância , Animais , Cardiotoxicidade , Bases de Dados de Compostos Químicos , Avaliação Pré-Clínica de Medicamentos , Humanos , Canais Iônicos/agonistas , Canais Iônicos/antagonistas & inibidores , Ligantes , Células Musculares/citologia , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Técnicas de Patch-Clamp , Relação Quantitativa Estrutura-Atividade , Células-Tronco/citologia , Células-Tronco/efeitos dos fármacos , Células-Tronco/metabolismo , Toxicologia/métodos
18.
Bioorg Med Chem ; 26(12): 3461-3467, 2018 07 23.
Artigo em Inglês | MEDLINE | ID: mdl-29789207

RESUMO

Phytochemical investigation of the stem bark of Myristica fatua Houtt. led to the isolation of a new compound 1 (3-tridecanoylbenzoic acid), along with six known acylphenols (2-7). All the compounds displayed moderate inhibitory activity on α-amylase and significant activity on α-glucosidase; however malabaricone B (6) and C (7) were identified as potent α-glucosidase inhibitors with IC50 values of 63.70 ±â€¯0.546, and 43.61 ±â€¯0.620 µM respectively. Acylphenols (compounds 3-7) also showed significant antiglycation property. The molecular docking and dynamics simulation studies confirmed the efficient binding of malabaricone C with C-terminus of human maltase-glucoamylase (2QMJ). Malabaricone B also enhanced the 2-NBDG [2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxy glucose] uptake in L6 myotubes. These findings demonstrate that acylphenols isolated from Myristica fatua Houtt. can be considered as a lead scaffold for the treatment of type II diabetes mellitus.


Assuntos
Inibidores de Glicosídeo Hidrolases/química , Hipoglicemiantes/química , Myristicaceae/química , Compostos Fitoquímicos/química , Sítios de Ligação , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/patologia , Inibidores de Glicosídeo Hidrolases/metabolismo , Inibidores de Glicosídeo Hidrolases/farmacologia , Humanos , Hipoglicemiantes/metabolismo , Hipoglicemiantes/farmacologia , Hipoglicemiantes/uso terapêutico , Simulação de Dinâmica Molecular , Células Musculares/citologia , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Myristicaceae/metabolismo , Compostos Fitoquímicos/metabolismo , Compostos Fitoquímicos/farmacologia , Casca de Planta/química , Casca de Planta/metabolismo , Extratos Vegetais/química , Caules de Planta/química , Caules de Planta/metabolismo , Estrutura Terciária de Proteína , Resorcinóis/química , Resorcinóis/metabolismo , Resorcinóis/farmacologia , alfa-Glucosidases/química , alfa-Glucosidases/metabolismo
19.
Int J Sport Nutr Exerc Metab ; 28(3): 284-293, 2018 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-29345166

RESUMO

Coffee is one of the most consumed beverages in the world, and it can improve insulin sensitivity, stimulating glucose uptake in skeletal muscle when adequate carbohydrate intake is observed. The aim of this review is to analyze the effects of coffee and coffee components on muscle glycogen metabolism. A literature search was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis, and seven studies were included, that explored the effects of coffee components on various substances and signaling proteins. In one of the studies with humans, caffeine was shown to increase glucose levels, Ca2+/calmodulin-dependent protein kinase phosphorylation, glycogen resynthesis rates, and glycogen accumulation after exercise. After intravenous injection of caffeine in rats, caffeine increased adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) phosphorylation, and glucose transport. In in vitro studies, caffeine raised AMPK and ACC phosphorylation, increasing glucose transport activity and reducing energy status in rat muscle cells. Cafestol and caffeic acid increased insulin secretion in rat beta cells and glucose uptake into human muscle cells. Caffeic acid also increased AMPK and ACC phosphorylation, reducing the energy status and increasing glucose uptake in rat muscle cells. Chlorogenic acid did not show any positive or negative effect. The findings from this review must be taken with caution due to the limited number of studies on the subject. In conclusion, various coffee components had a neutral or positive role in the metabolism of glucose and muscle glycogen, whereas no detrimental effect was described. Coffee beverages should be tested as an option for athletes' glycogen recovery.


Assuntos
Café/química , Exercício Físico , Glicogênio/metabolismo , Músculo Esquelético/fisiologia , Proteínas Quinases Ativadas por AMP/metabolismo , Acetil-CoA Carboxilase , Animais , Humanos , Resistência à Insulina , Células Secretoras de Insulina/efeitos dos fármacos , Células Musculares/efeitos dos fármacos , Fosforilação , Ratos
20.
Nutr Diabetes ; 8(1): 1, 2018 01 12.
Artigo em Inglês | MEDLINE | ID: mdl-29330446

RESUMO

BACKGROUND: Type 2 diabetes is characterized by dyslipidemia and the accumulation of lipids in non-adipose tissue, including skeletal muscle. Puerarin, which is a natural isoflavonoid isolated from the root of the plant Pueraria lobata, has been shown to have antidiabetic activity. However, the lipid-reducing effect of puerarin, in particular in skeletal muscle, has not yet been addressed. METHODS: We examined the effect of puerarin on mitochondrial function and the oxidation of fatty acids in the skeletal muscle of high-fat diet/streptozotocin-induced diabetic rats. RESULTS: Puerarin effectively alleviated dyslipidemia and decreased the accumulation of intramyocellular lipids by upregulating the expression of a range of genes involved in mitochondrial biogenesis, oxidative phosphorylation, the detoxification of reactive oxygen species, and the oxidation of fatty acids in the muscle of diabetic rats. Also, the effect of puerarin on mitochondrial biogenesis might partially involve the function of the µ-opioid receptor. In addition, puerarin decreased the trafficking of fatty acid translocase/CD36 to the plasma membrane to reduce the uptake of fatty acids by myocytes. In vitro studies confirmed that puerarin acted directly on muscle cells to promote the oxidation of fatty acids in insulin-resistant myotubes treated with palmitate. CONCLUSIONS: Puerarin improved the performance of mitochondria in muscle and promoted the oxidation of fatty acids, which thus prevented the accumulation of intramyocellular lipids in diabetic rats. Our findings will be beneficial both for elucidating the mechanism of the antidiabetic activity of puerarin and for promoting the therapeutic potential of puerarin in the treatment of diabetes.


Assuntos
Diabetes Mellitus Experimental/metabolismo , Ácidos Graxos/metabolismo , Isoflavonas/farmacologia , Mitocôndrias/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Pueraria/química , Animais , Antígenos CD36/metabolismo , Membrana Celular , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Dislipidemias/tratamento farmacológico , Dislipidemias/etiologia , Dislipidemias/metabolismo , Resistência à Insulina , Isoflavonas/uso terapêutico , Metabolismo dos Lipídeos/efeitos dos fármacos , Masculino , Mitocôndrias/fisiologia , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Músculo Esquelético/citologia , Músculo Esquelético/metabolismo , Fosforilação Oxidativa , Fitoterapia , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio/metabolismo , Receptores Opioides mu/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA